Sort by
Refine Your Search
-
nanomaterials as imaging probes or diagnostic agents or drug delivery system and perform experiments to test the properties and performance of the prepared materials in cells, biospecimen samples and animal
-
the EAC Transition Services program (i.e., Quest) and School Based Consultation and Training (i.e., Monarch); likewise, there will be potential collaborations and opportunities with other programs and
-
the lab’s mission while also contributing to collaborative, team-based efforts. We are seeking a scientist whose curiosity, creativity, and passion inspire them to pursue ambitious scientific directions
-
the Principal Investigator. NOTE: This role will be granted the opportunity to work from home regularly but must be able to commute to Emory University on a flexible weekly schedule based upon business needs
-
therapy resistance and identifying potential therapeutic targets to overcome resistance. The lab will integrate a variety of research approaches, including clinical genomics, CRISPR-based functional
-
but must be able to commute to Emory University on a flexible weekly schedule based upon business needs. Schedule is based on agreed upon guidelines of department. This role requires residency in
-
communication skills. 5. Experience in translation and dissemination of research findings to broader audiences is preferred, but not required. Salary will be based on the NIH postdoctoral research salary scale
-
specified by the Principal Investigator. NOTE: This role will be granted the opportunity to work from home regularly but must be able to commute to Emory University on a flexible weekly schedule based upon
-
interventional patient-based research related to pre-term infants and young children with cerebral palsy or motor delays. Specifically, this position will be funded through state initiatives to enhance care for
-
human cancer based on their cancer driver gene mutations. A new project in the lab is aimed at understanding the mechanism of natural killer mediated anti-tumor effects in LKB1-mutant lung adenocarcinoma